Access Resources
5741 - 5750 of 7540 Results
Title
Year
- AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease2017RESTRICTEDTitle: AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0416-xBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0416-xCitation Count: 102
- Aging modifies the effect of GCH1 RS11158026 on DAT uptake and Parkinson's disease clinical severity2017RESTRICTEDTitle: Aging modifies the effect of GCH1 RS11158026 on DAT uptake and Parkinson's disease clinical severityJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 50Issue #:Start Page: 39End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.10.006Best OA location URL: https://europepmc.org/articles/pmc5209269?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Association Between Pathology and Electroencephalographic Activity in Parkinson’s DiseaseJournal Name: Clinical EEG and NeurosciencePublisher: SAGE PublicationsVol: 49Issue #: 5Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1550059417696179Citation Count: 3
-
RESTRICTEDTitle: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0007-3Best OA location URL: https://www.nature.com/articles/s41531-017-0007-3.pdfCitation Count: 26
-
RESTRICTEDTitle: Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicityJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 98Issue #:Start Page: 122End Page: 136Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.11.004Best OA location URL: https://europepmc.org/articles/pmc5718210?pdf=renderCitation Count: 10
- Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene2017RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 26
- Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons2017RESTRICTEDTitle: Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic AxonsJournal Name: NeuronPublisher: Elsevier BVVol: 93Issue #: 4Start Page: 882End Page: 896.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.01.019Best OA location URL: http://www.cell.com/article/S0896627317300430/pdfCitation Count: 130
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2017RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 48
-
RESTRICTEDTitle: Regional volumetric change in Parkinson's disease with cognitive declineJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 373Issue #:Start Page: 88End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030Best OA location URL: http://manuscript.elsevier.com/S0022510X16308231/pdf/S0022510X16308231.pdfCitation Count: 24
- Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies2017RESTRICTEDTitle: Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studiesJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 2Start Page: 171End Page: 180Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24859Best OA location URL: https://kclpure.kcl.ac.uk/portal/files/62952075/Serontin_Transporter_in_Parkinson_s_disease_SERT_Accepted_GREEN_AAM.pdfCitation Count: 77